Skip to main content
. 2010 May 25;4:493–517. doi: 10.2147/opth.s8980

Table 1.

Search: Central

  1. diabetic macular edema.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 18

  2. diabetic macula odema.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 0

  3. Diabetic Retinopathy.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 843

  4. macular edema.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 53

  5. Macular Edema, Cystoid.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 74

  6. Macular Degeneration.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 609

  7. (DME or DMO or CME or CSME).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 197

  8. 6 or 4 or 1 or 3 or 7 or 2 or 5 1620

  9. angiogenesis inhibitors.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 96

  10. angiogenesis inhibitors.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 96

  11. endothelial growth factors.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 68

  12. vascular endothelial growth factors.mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] 65

  13. (macugen$ or pegaptanib$ or lucentis$ or rhufab$ or ranibizumab$ or bevacizumab$).tw. 120

  14. (anti adj2 VEGF$).tw.

  15. (endothelial adj2 growth adj2 factor$).tw. 265

  16. (macula$ adj2 swell$).tw. 1

  17. 11 or 13 or 10 or 9 or 12 or 15 or 14 414

  18. 8 and 17 71

  19. from 18 keep 10, 33, 45, 47, 51, 53–54... 9